FHLC Among Health Care ETFs
End-of-day Nov 20, 2026 · 27 Health care ETFs by 5Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.4% | −6.2% | −2.9% | +0.1% | +14.8% | +17.2% | +46.9% | +36.0% | +188.3% | +306.3% |
| Peer average | −1.3% | −6.4% | −4.5% | −5.9% | +13.4% | +17.5% | +58.2% | +19.5% | +146.1% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$146 of every $1,000 in FHLC is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly | Healthcare | 14.55% | $1,455.47 | 419K | $565.8M |
| 2 | JNJJohnson & Johnson | Healthcare | 8.65% | $865.37 | 1.3M | $336.4M |
| 3 | ABBVAbbvie | Healthcare | 6.74% | $674.14 | 924K | $262.1M |
| 4 | MRKMerck & NEW | Healthcare | 4.41% | $441.41 | 1.3M | $171.6M |
| 5 | UNHUnitedhealth Group | Healthcare | 4.04% | $403.88 | 475K | $157.0M |
| 6 | TMOThermo Fisher Scientific | Healthcare | 3.44% | $344.44 | 194K | $133.9M |
| 7 | AMGNAmgen | Healthcare | 3.19% | $318.71 | 282K | $123.9M |
| 8 | GILDGilead Sciences | Healthcare | 2.78% | $278.23 | 650K | $108.2M |
| 9 | ABTAbbott Laboratories | Healthcare | 2.43% | $243.47 | 911K | $94.7M |
| 10 | PFEPfizer | Healthcare | 2.11% | $211.23 | 3.0M | $82.1M |
| 11 | —Securities Lending CF | — | 2.00% | $200.45 | 77.9M | $77.9M |
| 12 | DHRDanaher | Healthcare | 1.95% | $195.06 | 333K | $75.8M |
| 13 | ISRGIntuitive Surgical | Healthcare | 1.94% | $194.09 | 185K | $75.5M |
| 14 | VRTXVertex Pharmaceuticals | Healthcare | 1.78% | $177.84 | 133K | $69.1M |
| 15 | 0Y6X.LMedtronic | Healthcare | 1.73% | $173.31 | 670K | $67.4M |
of the $110B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly & | 14.55% |
| 2 | JNJ | Johnson & Johnson | 8.65% |
| 3 | ABBV | Abbvie | 6.74% |
| 4 | MRK | Merck & NEW | 4.41% |
| 5 | UNH | Unitedhealth Group | 4.04% |
| 6 | TMO | Thermo Fisher Scientific | 3.44% |
| 7 | AMGN | Amgen | 3.19% |
| 8 | GILD | Gilead Sciences | 2.78% |
| 9 | ABT | Abbott Laboratories | 2.43% |
| 10 | PFE | Pfizer | 2.11% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 18, 2026 | Sep 22, 2026 | $0.25 |
| Jun 18, 2026 | Jun 23, 2026 | $0.26 |
| Mar 20, 2026 | Mar 24, 2026 | $0.23 |
| Dec 19, 2025 | Dec 23, 2025 | $0.27 |
| Sep 19, 2025 | Sep 23, 2025 | $0.26 |
| Jun 20, 2025 | Jun 24, 2025 | $0.26 |
| Mar 21, 2025 | Mar 25, 2025 | $0.25 |
| Dec 20, 2024 | Dec 24, 2024 | $0.26 |
| Sep 20, 2024 | Sep 24, 2024 | $0.25 |
| Jun 21, 2024 | Jun 25, 2024 | $0.24 |
| Mar 15, 2024 | Mar 20, 2024 | $0.24 |
| Dec 15, 2023 | Dec 20, 2023 | $0.22 |